Recurrence of abdominal large-vessel vasculitis and development of severe Sweet syndrome after a single cycle of 5-azacytidine in a patient with myelodysplastic syndrome

Eur J Haematol. 2014 Apr;92(4):362-4. doi: 10.1111/ejh.12249. Epub 2014 Jan 10.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antimetabolites, Antineoplastic / therapeutic use
  • Azacitidine / adverse effects*
  • Azacitidine / therapeutic use
  • Fatal Outcome
  • Humans
  • Male
  • Myelodysplastic Syndromes / complications*
  • Myelodysplastic Syndromes / drug therapy
  • Sweet Syndrome / diagnosis
  • Sweet Syndrome / drug therapy
  • Sweet Syndrome / etiology*
  • Sweet Syndrome / immunology
  • Vasculitis / diagnosis
  • Vasculitis / drug therapy
  • Vasculitis / etiology*
  • Vasculitis / immunology

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine